Latest filing published 23 Dec 2025 for Mydecine Innovations Group Inc.. Read the official filing
No signal scores available.
Ray Van Empel is a declared insider of Mydecine Innovations Group Inc., with filings sourced from SEDI. The record holds 75 filings, for trades running from 13 January 2021 to 22 October 2025.
Market trades split into 1 purchase (€381k) and 67 sales (€286k). Netting one side against the other leaves €95k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2025 alone, the filings show 1 purchase and 67 sales.
The record was last updated on 23 December 2025 with a transaction in Mydecine Innovations Group Inc. The last purchase on record was published on 23 December 2025, which is 302 days ago. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 73 declarations